[1]Lee,Sang-Bum;Park,YoungIn;Dong,Mi-Sook;Gong,Young-Dae[BioorganicandMedicinalChemistryLetters,2010,vol.20,#19,p.5900-5904]
1210935-33-3 
 
ethyl(2R)-2-(5Sa)-5-(3-chloro-4-hydroxy-2-methylphenyl)-6-(4-fluorophenyl)thieno2,3-dpyrimidin-4-yloxy-3-2-(pyrazin-2-ylmethoxy)phenylpropanoate 
 
C41H39ClFN5O5S 
[1]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;SERVIERMONDE-WO2015/97123,2015,A1Locationinpatent:Page/Pagecolumn259;260
[1]CurrentPatentAssignee:PFIZERINC-WO2017/201161,2017,A1Locationinpatent:Paragraph0755
1210935-33-3 
 
tert-butyl2-(cyanomethyl)-4-2-methylsulfinyl-7-(1-naphthyl)-6,8-dihydro-5H-pyrido3,4-dpyrimidin-4-ylpiperazine-1-carboxylate 
 
tert-butyl2-(cyanomethyl)-4-2-(3R)-1-methylpyrrolidin-3-ylmethoxy-7-(1-naphthyl)-6,8-dihydro-5H-pyrido3,4-dpyrimidin-4-ylpiperazine-1-carboxylate 
[1]CurrentPatentAssignee:PFIZERINC-WO2017/201161,2017,A1Locationinpatent:Paragraph0742
[2]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.;PFIZERINC-US2019/144444,2019,A1Locationinpatent:Paragraph1157-1158
1210935-33-3 
 
2-4-2-(3R)-1-methylpyrrolidin-3-ylmethoxy-7-(1-naphthyl)-6,8-dihydro-5H-pyrido3,4-dpyrimidin-4-ylpiperazin-2-ylacetonitriletrifluoroaceticacid 
[1]CurrentPatentAssignee:PFIZERINC-WO2017/201161,2017,A1